Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcgammaR1 (CD 64), FcgammaRIIA (CD 32a), and FcgammaRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers[1][2].
Molecular Weight:
(146.73 kDa)
Purity:
99.82
CAS Number:
[509077-98-9]
Target:
CD3
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
